JP6263305B1 - Medical sheet - Google Patents

Medical sheet Download PDF

Info

Publication number
JP6263305B1
JP6263305B1 JP2017148740A JP2017148740A JP6263305B1 JP 6263305 B1 JP6263305 B1 JP 6263305B1 JP 2017148740 A JP2017148740 A JP 2017148740A JP 2017148740 A JP2017148740 A JP 2017148740A JP 6263305 B1 JP6263305 B1 JP 6263305B1
Authority
JP
Japan
Prior art keywords
sheet
value
less
medical sheet
ion bombardment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017148740A
Other languages
Japanese (ja)
Other versions
JP2019025824A (en
Inventor
誠 澤田
誠 澤田
清治 星野
清治 星野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAMA BIO INC.
Original Assignee
TAMA BIO INC.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAMA BIO INC. filed Critical TAMA BIO INC.
Priority to JP2017148740A priority Critical patent/JP6263305B1/en
Application granted granted Critical
Publication of JP6263305B1 publication Critical patent/JP6263305B1/en
Priority to PCT/JP2018/013402 priority patent/WO2019026342A1/en
Priority to TW107115821A priority patent/TWI675054B/en
Publication of JP2019025824A publication Critical patent/JP2019025824A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C59/00Surface shaping of articles, e.g. embossing; Apparatus therefor
    • B29C59/16Surface shaping of articles, e.g. embossing; Apparatus therefor by wave energy or particle radiation, e.g. infrared heating
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances

Abstract

【解決課題】 イオン衝撃が施された面(部分)と,イオン衝撃が施されていな面(部分)とを区別できる医療用シートを提供する【解決手段】 粗面化部3のb値であるb1値と,第2の面7のb値であるb2値の差をΔbとしたときに,Δbが2以上11以下である医療用シート,並びにポリテトラフルオロエチレンを含むシートの第1の面5の全部又は一部をイオン衝撃により粗面化処理し,粗面化部5を形成する粗面化工程を含む医療用シートの製造方法であって,イオン衝撃は,10−7気圧以上10−1気圧以下の真空度にて連続的に行われる,方法。【選択図】図1[PROBLEMS] To provide a medical sheet capable of distinguishing a surface (part) subjected to ion bombardment and a surface (part) not subjected to ion bombardment. When the difference between a certain b1 value and the b2 value that is the b value of the second surface 7 is Δb, the medical sheet having Δb of 2 or more and 11 or less, and the first of the sheet containing polytetrafluoroethylene A method of manufacturing a medical sheet including a roughening step of roughening the entire surface 5 by ion bombardment to form a roughened portion 5, wherein the ion bombardment is 10 −7 atm or more. A method which is continuously performed at a vacuum degree of 10-1 atm or less. [Selection] Figure 1

Description

本発明は,医療用シートに関する。より詳しく説明すると,本発明は,生体補修材料や人工膜等に利用することができる医療用シートに関する。   The present invention relates to a medical sheet. More specifically, the present invention relates to a medical sheet that can be used for biological repair materials, artificial membranes, and the like.

特許4445697号公報及び特許5505752号公報には,生体修復材料が開示されている。   Japanese Patent No. 4445697 and Japanese Patent No. 5505572 disclose a biological repair material.

特許4445697号公報Japanese Patent No. 4445697 特許5505752号公報Japanese Patent No. 5505552

上記の公報に記載された生体修復材料は,イオン衝撃がされている面とそうでない面との区別がつきにくかった。生体修復材料や人工膜は,生体内に埋入等される。このため,着色料を用いることは難しく,また組成が変わると改めて承認を取り直す必要がある。このため,イオン衝撃が施された面(部分)と,イオン衝撃が施されていな面(部分)とを区別できる医療用シートが望まれた。さらには,医療用シートを用いて人工血管を作成した際に,血管内皮細胞が定着しやすいものが望まれた。   In the biomedical repair material described in the above publication, it is difficult to distinguish between the surface subjected to ion bombardment and the surface not subjected to ion bombardment. Living body repair materials and artificial membranes are embedded in the living body. For this reason, it is difficult to use colorants, and it is necessary to reapproval when the composition changes. Therefore, a medical sheet that can distinguish a surface (part) subjected to ion bombardment from a surface (part) not subjected to ion bombardment is desired. Furthermore, when an artificial blood vessel was created using a medical sheet, it was desired that a vascular endothelial cell is easily fixed.

本発明は,基本的には,ePTFE(延伸ポリテトラフルオロエチレン)などの樹脂シートの一方の面の全体又は一部にイオン衝撃などにより粗面化処理を行った後に加熱処理を施すことで,粗面化処理を施した部分のみが物性を変えずに変色するという知見に基づく。また,本発明は,イオン衝撃を行う際に,イオン衝撃装置の真空度を一定の値に維持し続け,イオン衝撃を連続的に行うことで,イオン衝撃の効果を高め,高い粗面化を達成できるという知見に基づく。   In the present invention, basically, the whole or a part of one surface of a resin sheet such as ePTFE (stretched polytetrafluoroethylene) is subjected to a surface treatment by ion bombardment and the like, and then a heat treatment is performed. This is based on the knowledge that only the roughened portion changes color without changing the physical properties. In addition, the present invention continuously maintains the degree of vacuum of the ion bombardment device at a constant value when performing ion bombardment, and continuously performs ion bombardment to enhance the effect of ion bombardment and achieve high surface roughness. Based on the knowledge that it can be achieved.

本発明は,医療用シートに関する。この医療用シートは,粗面化部3を有する第1の面5と,第1の面5反対に位置する第2の面7を有し,ポリテトラフルオロエチレンを含む医療用シート1である。
そして,粗面化部3は,表面粗さの値であるRz値が8以上14以下であり,Ra値が0.65以上1.5以下である。粗面化部3はイオン衝撃部により改質された部分であることが好ましい。粗面化部3は,第1の面5の一部であってもよいし,第1の面5の全体であってもよい。粗面化部3のb値であるb値と,第2の面7のb値であるb値の差をΔbとしたときに,Δbが2以上11以下であるものが好ましい。
The present invention relates to a medical sheet. This medical sheet is a medical sheet 1 having a first surface 5 having a roughened portion 3 and a second surface 7 positioned opposite to the first surface 5 and containing polytetrafluoroethylene. .
The roughened portion 3 has a surface roughness Rz value of 8 or more and 14 or less, and an Ra value of 0.65 or more and 1.5 or less. The roughened portion 3 is preferably a portion modified by an ion bombardment portion. The roughened portion 3 may be a part of the first surface 5 or the entire first surface 5. B 1 value and a b value of roughening unit 3, the difference between the b 2 values is b value of the second surface 7 when the [Delta] b, [Delta] b are those preferably 2 to 11.

本発明は,医療用シートの製造方法をも提供する。この方法は,ポリテトラフルオロエチレンを含むシートの第1の面5の全部又は一部をイオン衝撃により粗面化処理し,粗面化部5を形成する粗面化工程を含む医療用シートの製造方法である。そして,イオン衝撃は,10−7気圧以上10−1気圧以下の真空度にて連続的に行われる。この方法は,粗面化工程を経たポリテトラフルオロエチレンを含むシートを加熱し,医療用シートを得る加熱工程をさらに含むものが好ましい。粗面化部3は,表面粗さの値であるRz値が8以上14以下であり,Ra値が0.65以上1.5以下であるものが好ましい。加熱工程の例は,60℃以上300℃以下の温度で10秒以上10分以下シートを加熱する工程である。 The present invention also provides a method for producing a medical sheet. In this method, all or part of the first surface 5 of the sheet containing polytetrafluoroethylene is roughened by ion bombardment to form a roughened portion 5. It is a manufacturing method. The ion bombardment is continuously performed at a vacuum degree of 10 −7 atm or more and 10 −1 atm or less. This method preferably further includes a heating step of heating the sheet containing polytetrafluoroethylene that has undergone the roughening step to obtain a medical sheet. The roughened part 3 preferably has a surface roughness Rz value of 8 or more and 14 or less and a Ra value of 0.65 or more and 1.5 or less. The example of a heating process is a process of heating a sheet | seat for 10 second or more and 10 minutes or less at the temperature of 60 to 300 degreeC.

本発明によれば,イオン衝撃が施された面(部分)と,粗面化処理が施されていな面(部分)を区別できる医療用シートを製造できる医療用シートや,区別できる医療用シートを提供できる。また,この医療用シートを用いて人工血管を作成したところ,血管内皮細胞が定着しやすいものであった。   ADVANTAGE OF THE INVENTION According to this invention, the medical sheet which can manufacture the medical sheet which can distinguish the surface (part) to which the ion bombardment was given, and the surface (part) which was not roughened, and the medical sheet which can be distinguished Can provide. In addition, when an artificial blood vessel was created using this medical sheet, vascular endothelial cells were likely to settle.

図1は,本発明の医療用シートを示す概念図である。図1(a)は,第1の面を示し,図1(b)は第2の面を示す。FIG. 1 is a conceptual diagram showing a medical sheet of the present invention. FIG. 1A shows the first surface, and FIG. 1B shows the second surface.

以下,図面を用いて本発明を実施するための形態について説明する。本発明は,以下に説明する形態に限定されるものではなく,以下の形態から当業者が自明な範囲で適宜修正したものも含む。   Hereinafter, embodiments for carrying out the present invention will be described with reference to the drawings. The present invention is not limited to the embodiments described below, but includes those appropriately modified by those skilled in the art from the following embodiments.

本発明は,医療用シートに関する。医療用シートは,生体組織への癒着性・接着性が高い部分と,低い部分を有し,医療において用いることができるシートを意味する。このシートは,例えば,特定の組織を癒着させる一方,反対の面は組織とは癒着しないといった用い方をすることができる。また,この医療用シートを丸めることで,人工血管を得ることもできる。さらにこの医療用シートは,所定の形状に裁断等することで,人工弁や各種の移植に用いることができる。医療用シートは,特許4445697号公報に記載された生体修復材料であってもよいし,特許5505752号公報に記載された人工硬膜や筋肉に対する接着性を有する補填材料であってもよい。これら最も好ましい材料は,大きさが7.5cm×10.0cm〜26.0cm×34.0cmの範囲の楕円形状である。円形,四角形,三角形,及び特別に適合するように作られた形状のような,他の平面形状もまた本発明の使用に想定される。形状とは無関係に,適した移植可能なシート材料の大きさの範囲は小さくて1.0cm×1.0cmから大きくて50.0cm×50.0cmであり,5.0cm×5.0cm〜40.0cm×40.0cmの大きさの小片が好ましく,7.0cm×7.0cm〜20.0cm×20.0cmの範囲の小片であってもよい。   The present invention relates to a medical sheet. The medical sheet means a sheet that has a portion having high adhesion and adhesion to living tissue and a portion having low adhesion and can be used in medical treatment. This sheet can be used, for example, to adhere a specific tissue while the opposite surface does not adhere to the tissue. In addition, an artificial blood vessel can be obtained by rounding the medical sheet. Furthermore, this medical sheet can be used for artificial valves and various transplants by cutting into a predetermined shape. The medical sheet may be a living body repair material described in Japanese Patent No. 4445697 or a supplementary material having adhesion to an artificial dura mater or muscle described in Japanese Patent No. 5505572. These most preferred materials are elliptical in size ranging from 7.5 cm × 10.0 cm to 26.0 cm × 34.0 cm. Other planar shapes are also contemplated for use with the present invention, such as circles, squares, triangles, and shapes that are specifically tailored. Regardless of shape, suitable implantable sheet material sizes range from as small as 1.0 cm × 1.0 cm to as large as 50.0 cm × 50.0 cm, from 5.0 cm × 5.0 cm to 40 cm. A small piece having a size of 0.0 cm × 40.0 cm is preferable, and a small piece having a size of 7.0 cm × 7.0 cm to 20.0 cm × 20.0 cm may be used.

図1に示されるように,この医療用シート1は,粗面化部3を有する第1の面5と,第1の面5の反対に位置する第2の面7を有し,ポリテトラフルオロエチレンを含む医療用シート1である。図1は,本発明の医療用シートを示す概念図である。図1(a)は,第1の面を示し,図1(b)は第2の面を示す。粗面化部3とは,第2の面に比べて表面粗さが粗い部分を意味する。粗面化部3はイオン衝撃により改質された部分であってもよい。粗面化部3は,第1の面5全体であってもよいし,第1の面の特定の部分であってもよい。第1の面の特定の部分のみを粗面化したい場合は,例えば,粗面化しない部分をマスクした状態で,粗面化処理を施せばよい。粗面化部3は表面粗さの値であるRz値が8以上14以下(好ましくは,9以上13以下,又は9.5以上12.5以下,又は10以上12以下)であり,Ra値が0.65以上1.5以下(好ましくは0.7以上1.4以下,又は0.8以上1.3以下)であってもよい。これらの値は,JIS B 0601−2001に準拠して求めればよい。   As shown in FIG. 1, the medical sheet 1 has a first surface 5 having a roughened portion 3 and a second surface 7 positioned opposite to the first surface 5, and is made of polytetra This is a medical sheet 1 containing fluoroethylene. FIG. 1 is a conceptual diagram showing a medical sheet of the present invention. FIG. 1A shows the first surface, and FIG. 1B shows the second surface. The roughened portion 3 means a portion having a rougher surface roughness than the second surface. The roughened portion 3 may be a portion modified by ion bombardment. The rough surface portion 3 may be the entire first surface 5 or a specific portion of the first surface. When it is desired to roughen only a specific part of the first surface, for example, a roughening process may be performed in a state where a part that is not roughened is masked. The roughened portion 3 has a surface roughness Rz value of 8 or more and 14 or less (preferably 9 or more and 13 or less, or 9.5 or more and 12.5 or less, or 10 or more and 12 or less), and an Ra value. May be 0.65 or more and 1.5 or less (preferably 0.7 or more and 1.4 or less, or 0.8 or more and 1.3 or less). These values may be obtained in accordance with JIS B 0601-2001.

このような表面粗さを有する医療用シートは,加熱処理を行うことで,粗面化部とそうでない部分との変色の程度が異なるので,粗面化部とそうでない部分とを有する医療用シートを得ることができる。また,後述するように,上記の表面粗さを有する医療用シートを用いて人工血管を製造した場合,血管内皮細胞が定着しやすいものであった。   Since the medical sheet having such a surface roughness is subjected to heat treatment, the degree of discoloration differs between the roughened portion and the portion that is not, so the medical sheet having the roughened portion and the portion that is not. A sheet can be obtained. As will be described later, when an artificial blood vessel is produced using a medical sheet having the above surface roughness, vascular endothelial cells are likely to be established.

この医療用シートは,粗面化部とそうでない部分とを色味の違いに基づいて目視により判別できるものであることが好ましい。   This medical sheet is preferably one that can visually distinguish a roughened portion and a portion that is not so based on a difference in color.

Lab表色法は,JIS Z8730に規定される三刺激値X,Y,Zを用いて下記式から求められる。   The Lab colorimetric method is obtained from the following equation using tristimulus values X, Y, and Z defined in JIS Z8730.

L=10Y1/2 …(1)
a=17.5(1.02X−Y)/Y1/2 …(2)
b=7.0(Y−0.847Z)/Y1/2 …(3)
L:ハンター(R. S. Hunter)の色差式における明度指数。
a,b:ハンターの色差式における色座標。
X,Y,Z:X,Y,Z表色示における三刺激値X,Y,Zの値。
L = 10Y 1/2 (1)
a = 17.5 (1.02X−Y) / Y 1/2 (2)
b = 7.0 (Y−0.847Z) / Y 1/2 (3)
L: Lightness index in the color difference formula of Hunter (R. S. Hunter).
a, b: Color coordinates in Hunter's color difference formula.
X, Y, Z: Tristimulus values X, Y, Z in the X, Y, Z color display.

上記Lab表色のうち,Lは明度を表し,一般的には100〜0までの値である。明度とは色の明暗の状況,即ち明るさの度合をいう。このL値が大きいほど明るいことを意味する。   Among the Lab color specifications, L represents lightness and is generally a value from 100 to 0. Lightness refers to the lightness or darkness of a color, that is, the degree of brightness. A larger L value means brighter.

また,a,bは色彩を表し,a値は赤−緑方向,b値は黄−青方向を表す。従って,a値が大きくなると赤味が強くなり,小さくなると緑味が強くなり,b値が大きくなると黄味が強くなり,小さくなると青味が強くなる。   Further, a and b represent colors, the a value represents the red-green direction, and the b value represents the yellow-blue direction. Therefore, the red value becomes stronger as the value a becomes larger, the greenness becomes stronger when the value a becomes smaller, the yellowness becomes stronger as the value b becomes larger, and the blueness becomes stronger when the value a becomes smaller.

そして,この医療用シートは,粗面化部3のb値であるb1値と,第2の面7のb値であるb2値の差をΔbとしたときに,Δbが2以上11以下である。Δbは,通常b1値−b2値により求められる。Δbが4以上10以下であってもよいし,Δbが5以上,9.5以下でもよいし,Δbが6以上,9.5以下でもよいし,Δbが6以上,9以下でもよいし,Δbが7以上,8.5以下でもよい。このように本発明の医療用シートは,粗面化部が黄色味かかるので,粗面化部を有する面と,粗面化部を有していない面と区別することができる(なお,両面共に部分的に粗面化部を有していて,粗面化部の色味により粗面化部か否かを判断できるものであってもよい)。   In this medical sheet, when the difference between the b1 value that is the b value of the roughened portion 3 and the b2 value that is the b value of the second surface 7 is Δb, Δb is 2 or more and 11 or less. is there. Δb is normally obtained from the b1 value−b2 value. Δb may be 4 or more and 10 or less, Δb may be 5 or more and 9.5 or less, Δb may be 6 or more and 9.5 or less, Δb may be 6 or more and 9 or less, Δb may be 7 or more and 8.5 or less. As described above, the medical sheet of the present invention has a yellowish roughened portion, so that it can be distinguished from a surface having a roughened portion and a surface not having a roughened portion (both sides). Both may have a partially roughened portion and determine whether or not it is a roughened portion by the color of the roughened portion).

この医療用シートは,粗面化部が,若干赤みがかった色を呈することによっても区別することができる。特に,黄色系の蛍光灯のもとで,粗面化部を判別するためには,赤みがかった色味と,緑がかった色味とで区別を行うことができる。従来の医療用シートは,若干緑がかった色味をしていた。一方,本発明の医療用シートは若干赤みがかった色を呈した。この医療用シートは,粗面化部3のa値であるa1値と,第2の面7のa値であるa2値の差をΔaとしたときに,Δaが0.1以上1以下であることが好ましい。Δaは,通常a1値−a2値により求められる。Δaが0.15以上0.9以下であってもよいし,Δaが0.2以上,0.5以下でもよい。   This medical sheet can also be distinguished by the fact that the roughened portion exhibits a slightly reddish color. In particular, in order to determine the roughened surface under a yellow fluorescent lamp, it is possible to distinguish between a reddish hue and a greenish hue. Conventional medical sheets had a slightly greenish color. On the other hand, the medical sheet of the present invention exhibited a slightly reddish color. In this medical sheet, when the difference between the a1 value that is the a value of the roughened portion 3 and the a2 value that is the a value of the second surface 7 is Δa, Δa is 0.1 or more and 1 or less. Preferably there is. Δa is usually obtained from a1 value−a2 value. Δa may be 0.15 or more and 0.9 or less, and Δa may be 0.2 or more and 0.5 or less.

ポリテトラフルオロエチレンの例は,延伸ポリテトラフルオロエチレン(ePTFE)である。延伸ポリテトラフルオロエチレンの例は,米国特許第3953566号及び第4187390号に従って作られた,延伸多孔質ポリテトラフルオロエチレンである。なお,実施例では,基本的には,延伸ポリテトラフルオロエチレンを用いて実験を行った。一方,実施例で実証された効果は,ポリテトラフルオロエチレン系のシート全般に有効であると考えられる。   An example of polytetrafluoroethylene is expanded polytetrafluoroethylene (ePTFE). An example of expanded polytetrafluoroethylene is expanded porous polytetrafluoroethylene made according to US Pat. Nos. 3,953,566 and 4,187,390. In the examples, experiments were basically performed using expanded polytetrafluoroethylene. On the other hand, the effects demonstrated in the examples are considered to be effective for all polytetrafluoroethylene-based sheets.

次に本発明は,医療用シートの製造方法に関する。この方法は,
ポリテトラフルオロエチレンを含むシートの第1の面5の全部又は一部を粗面化し粗面化部5を形成する粗面化工程を含む。そして,粗面化工程は,10−7気圧以上10−1気圧以下の真空度にて連続的にイオン衝撃を行う。この方法は,粗面化工程を経たポリテトラフルオロエチレンを含むシートを加熱し,医療用シートを得る加熱工程と,を含んでもよい。従来,シートの表面を有機溶媒で洗浄していた。一方,シートの表面を有機溶媒で洗浄すると,有機溶媒がシート表面に残留し,シート表面に有機溶媒に由来する化合物が付着していた。このため,本発明は,シートの切断や,シートを粗面化する作業をクリーンルーム内で行い,シート表面を有機溶媒で洗浄しないことが好ましい。イオン衝撃は,後述のとおり,真空チャンバ内で連続的に行うものが好ましい。
Next, the present invention relates to a method for manufacturing a medical sheet. This method
A roughening step of roughening all or part of the first surface 5 of the sheet containing polytetrafluoroethylene to form the roughened portion 5 is included. In the roughening step, ion bombardment is continuously performed at a vacuum degree of 10 −7 atm or more and 10 −1 atm or less. This method may include a heating step of heating a sheet containing polytetrafluoroethylene that has undergone the roughening step to obtain a medical sheet. Conventionally, the surface of the sheet has been washed with an organic solvent. On the other hand, when the surface of the sheet was washed with an organic solvent, the organic solvent remained on the sheet surface, and a compound derived from the organic solvent adhered to the sheet surface. For this reason, in the present invention, it is preferable that the work of cutting the sheet or roughening the sheet is performed in a clean room and the sheet surface is not washed with an organic solvent. As described later, the ion bombardment is preferably performed continuously in a vacuum chamber.

粗面化工程における粗面化処理の例は,イオン注入(イオン衝撃),プラズマ処理,コロナ処理,UV処理,ケミカルブラスト及びサンドブラストである。この製造方法は,粗面化部3について,表面粗さの値であるRz値が8以上14以下であり,Ra値が0.65以上1.5以下であってもよい。つまり,従来の医療用シートよりやや表面を粗くした状態で,次の加工工程を行うことが好ましい。イオン注入については,例えば,従来のイオン注入法においてイオン衝撃中の真空チャンバ内(イオン衝撃装置内)の真空度を一定の範囲に保ち,連続的にイオン衝撃を行うこと,及びx軸方向及びy軸方向のイオン衝撃量を制御することにより,好ましい表面粗さを達成できる。イオン密度(ドース量φ)の例は,1×1013イオン/cm以上1×1016イオン/cm以下であり,1×1014イオン/cm以上1×1015イオン/cm以下でもよい。イオンの加速電圧の例は,30keV以上2000keV以下であり,70keV以上300keV以下でもよいし,100keV以上250keV以下でもよい。イオン照射時間の例は,1分以上5時間以下であり,10分以上2時間以下でもよいし,30分以上1時間以下でもよい。 Examples of the roughening treatment in the roughening step are ion implantation (ion bombardment), plasma treatment, corona treatment, UV treatment, chemical blasting and sandblasting. In this manufacturing method, the roughened portion 3 may have a surface roughness Rz value of 8 or more and 14 or less, and an Ra value of 0.65 or more and 1.5 or less. That is, it is preferable to perform the next processing step with the surface slightly rougher than the conventional medical sheet. With respect to ion implantation, for example, in the conventional ion implantation method, the degree of vacuum in the vacuum chamber (in the ion bombardment apparatus) during ion bombardment is kept within a certain range, and ion bombardment is performed continuously. A preferable surface roughness can be achieved by controlling the amount of ion bombardment in the y-axis direction. Examples of ion density (dose amount φ) are 1 × 10 13 ions / cm 2 or more and 1 × 10 16 ions / cm 2 or less, and 1 × 10 14 ions / cm 2 or more and 1 × 10 15 ions / cm 2 or less. But you can. An example of the ion acceleration voltage is 30 keV or more and 2000 keV or less, 70 keV or more and 300 keV or less, or 100 keV or more and 250 keV or less. The example of ion irradiation time is 1 minute or more and 5 hours or less, 10 minutes or more and 2 hours or less may be sufficient, and 30 minutes or more and 1 hour or less may be sufficient.

チャンバ内の真空度の例は,10−7気圧以上10−1気圧以下であり,10−6気圧以上10−2気圧以下でもよいし,10−5気圧以上5×10−3気圧以下でもよいし,10−4気圧以上10−3気圧以下でもよい。真空系自体は公知であり,真空チャンバと真空チャンバに接続されたポンプとを含む真空系を用いることで,所望の真空度を達成できる。適切に排気を行いつつイオン衝撃を行うことで,イオン衝撃を連続的に行うことができる。これにより良好な表面粗さを達成できたと考えられる。また,イオン照射量をx軸方向及びy軸方向で均一となるように制御することが好ましい。このためには,イオン照射用のノズルの位置や方向を制御すればよい。このようにすると,好ましい表面粗さを達成できる。例えば,このような状態に表面粗さを制御した後に,加熱処理を行うことで,医療用シートをより黄色みがからせることができる。 An example of the degree of vacuum in the chamber is 10 −7 atm to 10 −1 atm, 10 −6 atm to 10 −2 atm, or 10 −5 atm to 5 × 10 −3 atm. However , it may be 10 −4 atm or more and 10 −3 atm or less. The vacuum system itself is known, and a desired degree of vacuum can be achieved by using a vacuum system including a vacuum chamber and a pump connected to the vacuum chamber. By performing ion bombardment while properly evacuating, ion bombardment can be performed continuously. This is considered to have achieved good surface roughness. Further, it is preferable to control the ion irradiation amount to be uniform in the x-axis direction and the y-axis direction. For this purpose, the position and direction of the ion irradiation nozzle may be controlled. In this way, a preferable surface roughness can be achieved. For example, by controlling the surface roughness in such a state and then performing a heat treatment, the medical sheet can be made more yellowish.

PTFEの表面改質の例は,OやArガスを利用して、基材表面に官能基の導入や表面のエッチングを行う手法,有機モノマーをプラズマ下で重合させ,基材表面に薄膜を形成させるプラズマ重合法である。 Examples of surface modification of PTFE are methods of introducing functional groups on the surface of the substrate and etching the surface using O 2 or Ar gas, polymerizing organic monomers under plasma, and forming a thin film on the surface of the substrate. This is a plasma polymerization method to be formed.

加熱工程が,60℃以上300℃以下の温度で10秒以上1時間以下シートを加熱する工程であってもよい。加熱温度は,例えば,60℃以上150℃以下でもよく,100℃以上130℃以下でもよい。特にエチレンオキシドガス(EOG)滅菌を行う場合は,60℃以上100℃以下でもよく,65℃以上80℃以下でもよい。また,加熱温度は,110℃以上140℃以下でもよいし,110℃以上130℃以下でもよい。加熱時間は,加熱温度に合わせて適宜調整すればよく,10分以上45分以下でもよいし,15分以上30分以下でもよいし,20秒以上5分以下でもよいし,40秒以上2分以下でもよい。加熱工程を経たシートを冷却した後,粗面化部3のb値であるb1値と,第1の面5反対に位置する第2の面7のb値であるb2値の差をΔbとしたときに,Δbが2以上11以下となるようにシートを加熱することが好ましい。   The heating step may be a step of heating the sheet at a temperature of 60 ° C. or higher and 300 ° C. or lower for 10 seconds to 1 hour. The heating temperature may be, for example, 60 ° C. or more and 150 ° C. or less, or 100 ° C. or more and 130 ° C. or less. In particular, when performing ethylene oxide gas (EOG) sterilization, the temperature may be 60 ° C. or higher and 100 ° C. or lower, and may be 65 ° C. or higher and 80 ° C. or lower. The heating temperature may be 110 ° C. or higher and 140 ° C. or lower, or 110 ° C. or higher and 130 ° C. or lower. The heating time may be appropriately adjusted according to the heating temperature, may be 10 minutes or more and 45 minutes or less, 15 minutes or more and 30 minutes or less, 20 seconds or more and 5 minutes or less, or 40 seconds or more and 2 minutes. It may be the following. After cooling the sheet that has undergone the heating process, the difference between the b1 value that is the b value of the roughened portion 3 and the b2 value that is the b value of the second surface 7 located opposite to the first surface 5 is Δb. It is preferable to heat the sheet so that Δb is 2 or more and 11 or less.

クリーンルーム内で,ゴア社製ePTFEであるゴアテックス(登録商標)を10cm×10cmに切り取りePTFEシートを得た。ePTFEシートの表面を有機溶媒で洗浄せず,イオン注入装置を用いて,ePTFEシートにイオン衝撃を施し,表面を改質した。イオン衝撃の条件は以下の通りであった。
イオン:Ar
エネルギー:150KeV
イオン密度:5×1014イオン/cm
In a clean room, Gore-Tex (registered trademark), which is Gore's ePTFE, was cut into 10 cm × 10 cm to obtain an ePTFE sheet. The surface of the ePTFE sheet was not washed with an organic solvent, and an ion bombardment was applied to the ePTFE sheet using an ion implantation apparatus to modify the surface. The ion bombardment conditions were as follows.
Ion: Ar +
Energy: 150 KeV
Ion density: 5 × 10 14 ions / cm 2

イオン衝撃を行う間,イオン注入装置内の真空度を10−5気圧以上10−4気圧に維持した。また,イオン衝撃がシートのx軸方向及びy軸方向で均一となるように,イオンの照射量を調整した。 During the ion bombardment, the degree of vacuum in the ion implantation apparatus was maintained at 10 −5 atm or more and 10 −4 atm. Further, the ion irradiation amount was adjusted so that the ion bombardment was uniform in the x-axis direction and the y-axis direction of the sheet.

表面を改質したePTFEシートをオートクレーブ(120℃)にて,20分間加熱処理を行った。オートクレーブによる加熱後常温になるまでePTFEシートを静置した。このようにして医療用シートを得た。   The surface-modified ePTFE sheet was heat-treated in an autoclave (120 ° C.) for 20 minutes. The ePTFE sheet was allowed to stand until heating to normal temperature after heating with an autoclave. In this way, a medical sheet was obtained.

[参考例1]
オートクレーブによる加熱を行わなかった以外は,実施例1と同様にして医療用シートを得た(参考例1)。
[Reference Example 1]
A medical sheet was obtained in the same manner as in Example 1 except that heating by an autoclave was not performed (Reference Example 1).

得られた医療用シートの表面粗さを測定した。表面粗さは,オリンパス社製3D測定レーザー顕微鏡OLYMPUS OLS4000を用いた。得られた結果を表1に示す。   The surface roughness of the obtained medical sheet was measured. For the surface roughness, a Olympus 3D measurement laser microscope OLYMPUS OLS4000 was used. The obtained results are shown in Table 1.

Figure 0006263305
Figure 0006263305

得られた医療用シートの色調を測定した。色調の測定には,コニカミノルタ社製分光測色計を用いた。得られた結果を表2に示す。   The color tone of the obtained medical sheet was measured. A spectral colorimeter manufactured by Konica Minolta was used for the measurement of color tone. The obtained results are shown in Table 2.

Figure 0006263305
Figure 0006263305

目視により観察したところ,イオン衝撃を施した部分は,参考例1のものにくらべ明らかに黄色みがかっており,イオン衝撃の有無を明確に区別できる状態となっていた。   As a result of visual observation, the portion subjected to ion bombardment was clearly yellowish compared to that of Reference Example 1, and the presence or absence of ion bombardment was clearly distinguishable.

[実施例2]
オートクレープの温度を130℃をとした以外は実施例1と同様にして医療用シートを得た。
[Example 2]
A medical sheet was obtained in the same manner as in Example 1 except that the temperature of the autoclave was changed to 130 ° C.

[実施例3]
オートクレープの時間を3分をとした以外は実施例1と同様にして医療用シートを得た。
[Example 3]
A medical sheet was obtained in the same manner as in Example 1 except that the autoclave time was 3 minutes.

[実施例4]
ePTFEシートの代わりに,PTFEシートを用いた以外は実施例1と同様にして医療用シートを得た。
[Example 4]
A medical sheet was obtained in the same manner as in Example 1 except that a PTFE sheet was used instead of the ePTFE sheet.

[実施例5]
粗面化処理部を部分的とした以外は実施例1と同様にして医療用シートを得た。
[Example 5]
A medical sheet was obtained in the same manner as in Example 1 except that the roughening treatment part was partially used.

[実施例6]
イオン注入の代わりにサンドブラストを用いた以外は実施例1と同様にして医療用シートを得た。
[Example 6]
A medical sheet was obtained in the same manner as in Example 1 except that sandblasting was used instead of ion implantation.

[実施例7]
イオン注入の代わりにプラズマエッチングを施した以外は実施例1と同様にして医療用シートを得た。
[Example 7]
A medical sheet was obtained in the same manner as in Example 1 except that plasma etching was performed instead of ion implantation.

[実施例8]
オートクレープの代わりに70℃のEOG滅菌を施した以外は,実施例1と同様にして医療用シートを得た。
[Example 8]
A medical sheet was obtained in the same manner as in Example 1 except that 70 ° C. EOG sterilization was performed instead of the autoclave.

[実施例9]
ゴア社製ePTFEであるゴアテックス(登録商標)の代わりに,住友電工社製ポアフロン(登録商標)を用いた以外は,実施例1と同様にして医療用シートを得た。
[Example 9]
A medical sheet was obtained in the same manner as in Example 1 except that Porelon (registered trademark) manufactured by Sumitomo Electric was used instead of Gore-Tex (registered trademark), which is ePTFE manufactured by Gore.

実施例2〜7及び9のものは,実施例1のものに近いほど黄色みがかっていたが,実施例1のものが最も黄色が強く処理の有無を明確に把握できた。実施例8のものは,参考例1のものに比べて若干黄色みがみられ,注意して観察することにより,処理の有無を把握することができた。また,実施例1におけるイオン衝撃条件を種々変えて同様の実験を行ったところ,上記の実施例1〜9及び参考例1と同様の傾向を示した。   In Examples 2 to 7 and 9, the closer to that in Example 1, the more yellowish, but in Example 1, the yellowish color was the strongest and the presence or absence of treatment could be clearly understood. The sample of Example 8 was slightly yellowish compared to the sample of Reference Example 1, and the presence or absence of treatment could be grasped by careful observation. Moreover, when the same experiment was conducted by changing various ion bombardment conditions in Example 1, the same tendency as in Examples 1 to 9 and Reference Example 1 was shown.

[比較例1]
特許4445697号公報の実施例について,実際に行われた条件に従って医療用シートを作成した。
延伸ポリテトラフルオロエチレン(ePTFE)の表面を有機溶媒で洗浄した。その後,200KeVにてイオンビームを照射(Ne, 150keV, 5×1014 ions/cm)した。イオン衝撃を行うたびに真空度が落ちるため,イオン衝撃とイオン衝撃を中止して排気を行う作業を繰り返した。また,イオン衝撃の方向面での均一性を調整しなかった。得られた医療用シートの色調を測定した。色調の測定には,コニカミノルタ社製分光測色計を用いた。
[Comparative Example 1]
About the Example of patent 4445697 gazette, the medical sheet was created according to the conditions actually performed.
The surface of expanded polytetrafluoroethylene (ePTFE) was washed with an organic solvent. Thereafter, irradiation with an ion beam was performed at 200 KeV (Ne + , 150 keV, 5 × 10 14 ions / cm 2 ). Every time ion bombardment is performed, the degree of vacuum drops. Also, the uniformity in the direction of ion bombardment was not adjusted. The color tone of the obtained medical sheet was measured. A spectral colorimeter manufactured by Konica Minolta was used for the measurement of color tone.

比較例1において得られた医療用シートの表面粗さは,Rz値が平均値5(標準偏差0.5)であり,Ra値が平均値0.52(標準偏差0.05)であった。このシートは,イオンビームを照射した面と照射しない面との色味を区別することができなかった。このシートの粗面化部分のb値の平均は負の値であると考えられる。   As for the surface roughness of the medical sheet obtained in Comparative Example 1, the Rz value was an average value 5 (standard deviation 0.5), and the Ra value was an average value 0.52 (standard deviation 0.05). . This sheet could not distinguish the color of the surface irradiated with the ion beam and the surface not irradiated. The average b value of the roughened portion of the sheet is considered to be a negative value.

[実施例10]
比較例1において得られた医療用シートをオートクレープ(120℃)にて,20分間加熱処理を行った。オートクレープによる加熱後常温になるまでePTFEシートを静置した。このようにして医療用シートを得た。目視により観察したところ,イオン衝撃を施した部分は,比較例2のものにくらべ若干識別できるように色味がついていた。このシートのb値は2〜3程度であった。
[Example 10]
The medical sheet obtained in Comparative Example 1 was heat-treated for 20 minutes in an autoclave (120 ° C.). The ePTFE sheet was allowed to stand until the temperature reached room temperature after heating with an autoclave. In this way, a medical sheet was obtained. As a result of visual observation, the portion subjected to ion bombardment was colored so that it could be distinguished slightly from that of Comparative Example 2. The b value of this sheet was about 2 to 3.

上記した実施例,参考例及び比較例におけるシートを用い,内径が4mm,6mmの人工血管(医療用チューブ)を作成した。作成した人工血管にヒト全血を1,2,4,8,24,48時間流入した際の血液の凝固成分を観察した。その結果,実施例1のものは,極めて早期に血栓膜が形成され,その血栓膜の上に血管内皮細胞が定着し良好な人工血管であった。一方,比較例1のものは,血液の漏れ等はなく人工血管として機能するものの,血管内皮細胞が定着するまで長時間かかった。それ以外の実施例や参考例は,実施例1と比較例1の間の性能を発揮した。   Artificial blood vessels (medical tubes) having inner diameters of 4 mm and 6 mm were prepared using the sheets in the above-described Examples, Reference Examples and Comparative Examples. The blood coagulation component was observed when human whole blood flowed into the created artificial blood vessel for 1, 2, 4, 8, 24, 48 hours. As a result, in Example 1, a thrombus film was formed very early, and vascular endothelial cells were established on the thrombus film, which was a good artificial blood vessel. On the other hand, the sample of Comparative Example 1 did not leak blood and functioned as an artificial blood vessel, but it took a long time for vascular endothelial cells to settle. The other examples and reference examples exhibited the performance between Example 1 and Comparative Example 1.

本発明は,医療機器の分野で利用されうる。   The present invention can be used in the field of medical devices.

1 医療用シート, 3 粗面化部, 5 第1の面, 7 第2の面   DESCRIPTION OF SYMBOLS 1 Medical sheet, 3 Roughening part, 5 1st surface, 7 2nd surface

Claims (3)

粗面化部を有する第1の面(5)と,第1の面(5)反対に位置する第2の面(7)を有し,ポリテトラフルオロエチレンを含む医療用シート(1)であって,
前記粗面化部(3)は,表面粗さの値であるRz値が8以上14以下であり,Ra値が0.65以上1.5以下であり,
前記粗面化部(3)のb値であるb 値と,第2の面(7)のb値であるb 値の差をΔbとしたときに,Δbが2以上11以下である,医療用シート。
A medical sheet (1) having a first surface (5) having a roughened portion and a second surface (7) located opposite to the first surface (5) and comprising polytetrafluoroethylene There,
The roughened portion (3) has a surface roughness Rz value of 8 or more and 14 or less, a Ra value of 0.65 or more and 1.5 or less ,
Wherein b 1 value and a b value of roughening portion (3), the difference between the b 2 values is b value of the second surface (7) when the [Delta] b, [Delta] b is 2 to 11 , Medical sheet.
請求項1に記載の医療用シートであって,前記粗面化部(3)はイオン衝撃部により改質された部分である,医療用シート。   The medical sheet according to claim 1, wherein the roughened portion (3) is a portion modified by an ion bombardment portion. 請求項1に記載の医療用シートであって,前記粗面化部(3)は第1の面(5)の一部である,医療用シート。   The medical sheet according to claim 1, wherein the roughened portion (3) is a part of the first surface (5).
JP2017148740A 2017-08-01 2017-08-01 Medical sheet Active JP6263305B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2017148740A JP6263305B1 (en) 2017-08-01 2017-08-01 Medical sheet
PCT/JP2018/013402 WO2019026342A1 (en) 2017-08-01 2018-03-29 Medical sheet
TW107115821A TWI675054B (en) 2017-08-01 2018-05-09 Medical sheet and method of manufacturing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017148740A JP6263305B1 (en) 2017-08-01 2017-08-01 Medical sheet

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017241116A Division JP2019025293A (en) 2017-12-15 2017-12-15 Medical sheet

Publications (2)

Publication Number Publication Date
JP6263305B1 true JP6263305B1 (en) 2018-01-17
JP2019025824A JP2019025824A (en) 2019-02-21

Family

ID=60989233

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017148740A Active JP6263305B1 (en) 2017-08-01 2017-08-01 Medical sheet

Country Status (3)

Country Link
JP (1) JP6263305B1 (en)
TW (1) TWI675054B (en)
WO (1) WO2019026342A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006230639A (en) * 2005-02-24 2006-09-07 Institute Of Physical & Chemical Research Catheter with reformed contact part with living body
JP2007020590A (en) * 2003-08-19 2007-02-01 Institute Of Physical & Chemical Research Material for aneurysm curing
JP2009504330A (en) * 2005-08-18 2009-02-05 ボストン サイエンティフィック リミテッド Surface modification of ePTFE and implant using the same
JP4445697B2 (en) * 2002-08-30 2010-04-07 独立行政法人理化学研究所 Biological repair material having affinity with biological tissue adhesive
JP5505752B2 (en) * 2001-04-23 2014-05-28 独立行政法人理化学研究所 Artificial dura mater having cell adhesion and method for producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080255663A1 (en) * 2007-04-13 2008-10-16 Akpek Esen K Artificial Cornea and Method of Making Same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505752B2 (en) * 2001-04-23 2014-05-28 独立行政法人理化学研究所 Artificial dura mater having cell adhesion and method for producing the same
JP4445697B2 (en) * 2002-08-30 2010-04-07 独立行政法人理化学研究所 Biological repair material having affinity with biological tissue adhesive
JP2007020590A (en) * 2003-08-19 2007-02-01 Institute Of Physical & Chemical Research Material for aneurysm curing
JP2006230639A (en) * 2005-02-24 2006-09-07 Institute Of Physical & Chemical Research Catheter with reformed contact part with living body
JP2009504330A (en) * 2005-08-18 2009-02-05 ボストン サイエンティフィック リミテッド Surface modification of ePTFE and implant using the same

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
APPLIED SURFACE SCIENCE, 2014, VOL. 314, P. 670-678, JPN6017037072 *
NEUROLOGICAL SURGERY, 2004, VOL. 32, NO. 4, P. 339-344, JPN6017037067 *
SURFACE & COATINGS TECHNOLOGY, 2011, VOL. 206, P. 841-844, JPN6017037076 *
日本機械学会関東支部ブロック合同講演会 2007さいたま/第3回埼玉ブロック大会 講演論文集, 2007,09., JPN6017037063 *
材料の科学と工学, 2009, VOL. 46, NO. 4, P. 169-173, JPN6017037078 *
理研シンポジウム第18回「マイクロファブリケーション研究の最新動向」, 2006, P. 74-77, JPN6017037069 *
表面科学, 2011, VOL. 32, NO. 9, P. 551-556, JPN6017037065 *

Also Published As

Publication number Publication date
WO2019026342A1 (en) 2019-02-07
JP2019025824A (en) 2019-02-21
TWI675054B (en) 2019-10-21
TW201910400A (en) 2019-03-16

Similar Documents

Publication Publication Date Title
US5376400A (en) Combined plasma and gamma radiation polymerization method for modifying surfaces
US6464889B1 (en) Surface modification of medical implants
US5804263A (en) Combined plasma and gamma radiation polymerization method for modifying surfaces
Chu et al. Plasma-surface modification of biomaterials
WO2018196055A1 (en) Polymer material surface modification method and product and use thereof
KR20160029985A (en) A method for generating plasma uniformly on dielectric material
JP6263305B1 (en) Medical sheet
EP1810700B1 (en) Method of producing surface-treated intraocular lens and intraocular lens for inhibiting secondary cataract
JPS63500642A (en) Polymer intraocular lens with improved surface properties
JP2019025293A (en) Medical sheet
JP6426812B1 (en) Medical seat
Mirenghi et al. Growth of human endothelial cells on plasma-treated polyethyleneterephthalate surfaces
WO2003030959A1 (en) Corneal repair device
WO2016071290A1 (en) Process for obtaining a silicone patch having at least one surface coated with carbon applied by arc deposition for the replacement of a portion of bladder wall
WO2014103688A1 (en) Material for cell growth, tissue regenerating membrane and tissue regeneration method
WO2003030958A1 (en) Corneal graft
Akay et al. Evaluation of helium plasma surface modification on tensile bond strength of denture base materials: a scanning electron microscope study
EP3970762A1 (en) Method for manufacturing eptfe artificial blood vessels having improved hemocompatibility via selective plasma etching
RU2579314C1 (en) Method for plasma-immersion ion modification of surface of article made from alloy based on titanium nickelide for medical purposes
WO2024051011A1 (en) Polymeric, implantable material with both antibacterial and proosteogenic properties and preparation method therefor
Chan et al. Cyclopropylamine modified plasma polymerised poly (methyl methacrylate) thin films for cell culture
TW201924731A (en) Artificial pericardial membrane sheet
JP2022177309A (en) Manufacturing method of medical equipment
JPS5827937B2 (en) surgical contact lenses
OA18243A (en) Process for obtaining a silicone patch having at least one surface coated with carbon applied by arc deposition for the replacement of a portion of bladder wall.

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170803

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20170803

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20170815

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171006

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20171205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171215

R150 Certificate of patent or registration of utility model

Ref document number: 6263305

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250